• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY ASSURA VR ICD, US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY ASSURA VR ICD, US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD1357-40Q
Device Problems Failure to Capture (1081); Failure to Deliver Shock/Stimulation (1133); Low impedance (2285); Battery Problem (2885)
Patient Problem Ventricular Tachycardia (2132)
Event Date 10/15/2020
Event Type  Injury  
Manufacturer Narrative
The device is included in the battery performance alert advisory issued by abbott on 28 august 2017.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Related manufacturer reference number: 2017865-2020-16833.Following the battery performance alert (bpa) advisory, a bpa was received by the clinician and the device was explanted.Patient was stable after the procedure.It was also noted that patient had a ventricular tachycardia episode that required external defibrillation due to shock therapy being disabled.The bpa also caused loss of capture and low out of range pacing and defibrillation impedance for the right ventricular lead.Physician also saw that the patient's right ventricular lead's suture sleeve was no longer in place during the bpa generator change procedure.Lead had normal measurements and was connected to new device.
 
Manufacturer Narrative
Premature battery depletion was confirmed by analysis.No sources of high current were noted.The cause of the premature battery depletion was consistent with lithium (li) cluster formation.From these analyses, in the absence of high current draw, it is probable that the premature battery depletion was caused by a lithium cluster induced short circuit.Li clusters are a known depletion mechanism for these advisory products that has been investigated and associated with a field action in october 2016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORTIFY ASSURA VR ICD, US
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key10758936
MDR Text Key213841292
Report Number2017865-2020-16832
Device Sequence Number1
Product Code LWS
UDI-Device Identifier05414734507974
UDI-Public05414734507974
Combination Product (y/n)N
PMA/PMN Number
P910023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup
Report Date 12/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2016
Device Model NumberCD1357-40Q
Device Catalogue NumberCD1357-40Q
Device Lot Number4765486
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/02/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/15/2020
Initial Date FDA Received10/29/2020
Supplement Dates Manufacturer Received12/16/2020
Supplement Dates FDA Received12/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0115-2017
Patient Sequence Number1
Treatment
DURATA STS LEAD; DURATA STS LEAD
Patient Outcome(s) Required Intervention;
-
-